Walleye Capital LLC Sells 12,692 Shares of Biotech Acquisition (NASDAQ:BIOT)

Walleye Capital LLC reduced its position in shares of Biotech Acquisition (NASDAQ:BIOTGet Rating) by 13.4% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 81,797 shares of the company’s stock after selling 12,692 shares during the period. Walleye Capital LLC’s holdings in Biotech Acquisition were worth $807,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in BIOT. DeepCurrents Investment Group LLC bought a new position in shares of Biotech Acquisition in the fourth quarter valued at approximately $174,000. BCK Capital Management LP acquired a new stake in Biotech Acquisition during the 1st quarter valued at $268,000. Spartan Fund Management Inc. bought a new position in Biotech Acquisition in the 1st quarter valued at $302,000. Commonwealth of Pennsylvania Public School Empls Retrmt SYS acquired a new position in Biotech Acquisition in the first quarter worth $493,000. Finally, Glazer Capital LLC bought a new stake in shares of Biotech Acquisition during the fourth quarter worth $1,088,000. 86.02% of the stock is currently owned by institutional investors and hedge funds.

Biotech Acquisition Price Performance

Biotech Acquisition stock opened at $9.91 on Tuesday. Biotech Acquisition has a 12-month low of $8.30 and a 12-month high of $10.41. The stock has a 50-day simple moving average of $9.88 and a 200 day simple moving average of $9.84.

About Biotech Acquisition

(Get Rating)

Biotech Acquisition Company does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.

See Also

Want to see what other hedge funds are holding BIOT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Biotech Acquisition (NASDAQ:BIOTGet Rating).

Institutional Ownership by Quarter for Biotech Acquisition (NASDAQ:BIOT)

Receive News & Ratings for Biotech Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biotech Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.